Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Sep;76(3):238–242. doi: 10.1136/hrt.76.3.238

Changing from intensive anticoagulation to treatment with aspirin alone for coronary stents: the experience of one centre in the United Kingdom.

N G Stephens 1, P F Ludman 1, M C Petch 1, P M Schofield 1, L M Shapiro 1
PMCID: PMC484513  PMID: 8868982

Abstract

OBJECTIVE: To investigate whether an elective change in the anticoagulation protocol for patients with coronary stents affected clinical outcomes and length of hospital stay. DESIGN: Retrospective observational study of a consecutive series of patients treated with coronary stents over an 18 month period from April 1994 to October 1995. BACKGROUND: Intensive anticoagulation regimens are used in many UK centres to reduce the risk of coronary stent thrombosis. Recent data have called into question the necessity for full anticoagulation and favourable results have been reported with antiplatelet agents alone. The results from a tertiary referral centre were investigated during a period where an elective change in policy was made: an initial 70 patients were treated intensively with intravenous heparin and with warfarin and aspirin; subsequently 94 were treated with aspirin and deployment of a high pressure balloon only. METHODS: Review of case notes, angiograms, and a database of intervention procedures and telephone interview. Classic epidemiological techniques, as well as linear regression and logistic regression, were used to model the outcomes of major procedural complications and length of hospital stay. PATIENTS: 164 patients treated with 196 coronary stents. RESULTS: There were 22 (13.4%) major complications (coronary bypass grafting 11, subacute thrombosis 6, tamponade 2, myocardial infarction 1, death 2). With logistic regression, the risk of major complication was shown not to be affected by anticoagulation (relative risk (RR) 1.03; P = 0.97). Significant determinants of risk included acute vessel closure as an indication for stenting (RR = 80.6; P < 0.001) and sex (male: female RR = 0.19; P = 0.02). The median length of stay (LOS) was 5 days (1-45). Use of a linear regression model showed that anticoagulation added 4.5 days and a major complication added a further 4.5 days to a baseline length of stay of 3.2 days (R2 = 0.32; P < 0.001). CONCLUSION: This is a report of coronary stenting as part of usual clinical practice in one British tertiary referral centre. In this experience, treatment with aspirin alone is probably as safe as intensive anticoagulation, and has the benefit of reducing length of stay by more than 50% to 3.2 days in an uncomplicated case.

Full text

PDF
238

Images in this article

242Image
on p.242

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell M. R., Grill D. E., Garratt K. N., Berger P. B., Gersh B. J., Holmes D. R., Jr Long-term outcome of women compared with men after successful coronary angioplasty. Circulation. 1995 Jun 15;91(12):2876–2881. doi: 10.1161/01.cir.91.12.2876. [DOI] [PubMed] [Google Scholar]
  2. Colombo A., Hall P., Nakamura S., Almagor Y., Maiello L., Martini G., Gaglione A., Goldberg S. L., Tobis J. M. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995 Mar 15;91(6):1676–1688. doi: 10.1161/01.cir.91.6.1676. [DOI] [PubMed] [Google Scholar]
  3. Fischman D. L., Leon M. B., Baim D. S., Schatz R. A., Savage M. P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994 Aug 25;331(8):496–501. doi: 10.1056/NEJM199408253310802. [DOI] [PubMed] [Google Scholar]
  4. Kuntz R. E., Piana R., Pomerantz R. M., Carrozza J., Fishman R., Mansour M., Safian R. D., Baim D. S. Changing incidence and management of abrupt closure following coronary intervention in the new device era. Cathet Cardiovasc Diagn. 1992 Nov;27(3):183–190. doi: 10.1002/ccd.1810270306. [DOI] [PubMed] [Google Scholar]
  5. Palomäki P., Miettinen H., Mustaniemi H., Lehto S., Pyörälä K., Mähönen M., Tuomilehto J. Diagnosis of acute myocardial infarction by MONICA and FINMONICA diagnostic criteria in comparison with hospital discharge diagnosis. J Clin Epidemiol. 1994 Jun;47(6):659–666. doi: 10.1016/0895-4356(94)90213-5. [DOI] [PubMed] [Google Scholar]
  6. Pratt C. M., Hallstrom A., Theroux P., Romhilt D., Coromilas J., Myles J. Avoiding interpretive pitfalls when assessing arrhythmia suppression after myocardial infarction: insights from the long-term observations of the placebo-treated patients in the Cardiac Arrhythmia Pilot Study (CAPS) J Am Coll Cardiol. 1991 Jan;17(1):1–8. doi: 10.1016/0735-1097(91)90697-8. [DOI] [PubMed] [Google Scholar]
  7. Savage M. P., Fischman D. L., Schatz R. A., Teirstein P. S., Leon M. B., Baim D., Ellis S. G., Topol E. J., Hirshfeld J. W., Cleman M. W. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol. 1994 Nov 1;24(5):1207–1212. doi: 10.1016/0735-1097(94)90099-x. [DOI] [PubMed] [Google Scholar]
  8. Serruys P. W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489–495. doi: 10.1056/NEJM199408253310801. [DOI] [PubMed] [Google Scholar]
  9. Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987 Mar 19;316(12):701–706. doi: 10.1056/NEJM198703193161201. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES